高勇 主任医师，教授
硕士招生类型：学术型；专业型
硕士招生专业：肿瘤学
博士招生类型：学术型；专业型
博士招生专业：肿瘤学
所在院系：附属东方医院
联系方式：drgaoyong@163.com
课题组链接：
研究方向
主要任职
科研业绩

1. 消化道肿瘤发生与靶向精准治疗/ Gastrointestinal TumorGeneration and Targeted Precision Therapy
2. 胃肠肿瘤免疫微环境与免疫治疗/ Immune Microenvironment and Immunotherapy of GastrointestinalTumors




同济大学附属东方医院消化肿瘤专科主任/ Director of digestivetumor department, East Hospital Affiliated to Tongji University
上海市浦东新区肿瘤专业委员会主任委员/ Chairman of the CancerProfessional Committee of Shanghai Pudong New District
中国医药教育协会盆腔肿瘤专业委员会副主任委员/ Vice-Chairman of PelvicCancer Professional Committee of China Medical Education Association
中华医学会肿瘤姑息治疗专业委员会委员/ Professional Committee onPalliative Treatment of Cancer, Chinese Medical Association
CSCO胰腺癌专家委员会委员/ Committee Member of CSCO PancreaticCancer Expert Committee
CSCO肝癌专家委员会委员/Committee Memberof CSCO Hepatocellular Carcinoma Expert Committee







Funds:
1. 国家自然科学基金**FoxM1调控TGF-β1/Smad信号通路促进乳腺癌EMT机制研究。
课题负责人60万2013.01-2016.12/National Natural Science Foundation of China(**), 2013.01-2016.12
2. 国家自然科学基金**KLF4调控uPAR在肝细胞癌发生上皮－间质转化中的作用和机制研究 课题负责人55万2012.01-2015.12/ National Natural Science Foundation of China(**),2012.01-2015.12
3. 上海市医学重点专科肿瘤专科（ZK2012A26）, 课题负责人120万2013.01-2016.12/ Oncology Speciality of Shanghai Key Medical Speciality（ZK2012A26）, 2013.01-2016.12
4. 上海市浦东新区领先人才，浦东新区PWR12013-02，负责人40万2013.11-2017.10 /Leading Talents in Shanghai Pudong New Area(PWR12013-02), 2013.11-2017.10
5. 浦东新区卫生系统重点学科群，浦东新区卫计委PWZxq2014-0，负责人150万2014.04-2017.03/Key Subjects Group of Health System in Pudong New Area(PWZxq2014-0),2014.04-2017.03
6. 国家自然科学基金**KLF4通过HNF-6信号通路影响肝癌细胞分化的机制研究。
课题负责人72万2015.01-2018.12/National Natural Science Foundation of China(**), 2015.01-2018.12
7. 国家自然科学基金**RNA编辑酶ADAR1调控PARP1在胃癌细胞化疗耐药中的作用及机制研究。课题负责人65万2017.01-2020.12/ NationalNatural Science Foundation of China(**), 2017.01-2020.12
Bibliography:
1. Yu S, Gautam N, Quan M,Gao Y. RSRC1 suppresses gastric cancer cell proliferation and migration byregulating PTEN expression. Mol Med Rep. 2019 Aug;20(2):1747-1753. doi:10.3892/mmr.2019.10409. Epub 2019 Jun 21. PubMed PMID: **.
2. Li Y, Yu S, Wang X, Ye X,He B, Quan M, Gao Y. SRPK1 facilitates tumor cell growth via modulating thesmall nucleolar RNA expression in gastric cancer. J Cell Physiol. 2019Aug;234(8):13582-13591. doi: 10.1002/jcp.28036. Epub 2019 Jan 11. PubMed PMID:**.
3. Yu S, Wang X, Dou N, ZhouJ, Gao Y, Li Y. B-cell lymphoma-2-associated transcription factor 1 isoverexpressed and contributes to sorafenib resistance in hepatocellularcarcinoma. Hepatol Res. 2019 Jun 24;. doi: 10.1111/hepr.13395. [Epub ahead ofprint] PubMed PMID: **.
4. Li L, Yu S, Wu Q, Dou N,Li Y, Gao Y. KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma CellGrowth and Migration via GSK-3β Signaling. Int J Biol Sci. 2019;15(5):953-961.doi: 10.7150/ijbs.30857. eCollection 2019. PubMed PMID: **; PubMedCentral PMCID: PMC**.
5. Chen J, Li L, Zhou Z, YuS, Li Y, Gao Y. FAPP2 promotes tumor cell growth in human colon cancer throughactivation of Wnt signaling. Exp Cell Res. 2019 Jan 1;374(1):12-18. doi:10.1016/j.yexcr.2018.11.002. Epub 2018 Nov 5. PubMed PMID: **.
6. Dou N, Yang D, Yu S, WuB, Gao Y, Li Y. SNRPA enhances tumour cell growth in gastric cancer throughmodulating NGF expression. Cell Prolif. 2018 Oct;51(5):e12484. doi:10.1111/cpr.12484. Epub 2018 Jul 24. PubMed PMID: **.
7. Yu S, Li L, Wu Q, Dou N,Li Y, Gao Y. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotesgastric cancer growth and metastasis via mechanistic target of rapamycinactivation. Int J Oncol. 2018 Jun;52(6):2011-2020. doi: 10.3892/ijo.2018.4329.Epub 2018 Mar 20. PubMed PMID: **.
8. Zhang Y, Ye X, Chen L, WuQ, Gao Y, Li Y. PARI functions as a new transcriptional target of FOXM1involved in gastric cancer development. Int J Biol Sci. 2018;14(5):531-541.doi: 10.7150/ijbs.23945. eCollection 2018. PubMed PMID: **; PubMedCentral PMCID: PMC**.
9. Wu Q, Yu S, Chen J, Li Y,Gao Y. Downregulation of STRAP promotes tumor growth and metastasis inhepatocellular carcinoma via reducing PTEN level. IUBMB Life. 2018Feb;70(2):120-128. doi: 10.1002/iub.1707. Epub 2017 Dec 28. PubMed PMID:**.
10. Wang Y, Jiang J, Li Q, MaH, Xu Z, Gao Y. KAP1 is overexpressed in hepatocellular carcinoma and itsclinical significance. Int J Clin Oncol. 2016 Oct;21(5):927-933. doi:10.1007/s10147-016-0979-8. Epub 2016 Apr 19. PubMed PMID: **.
11. Wang X, He B, Gao Y, LiY. FOXR2 contributes to cell proliferation and malignancy in humanhepatocellular carcinoma. Tumour Biol. 2016 Aug;37(8):10459-67. doi:10.1007/s13277-016-4923-3. Epub 2016 Feb 5. PubMed PMID: **.
12. Ye X, Zhang Y, Wang X, LiY, Gao Y. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 ingastric cancer. IUBMB Life. 2016 Apr;68(4):320-7. doi: 10.1002/iub.1486. Epub2016 Mar 7. PubMed PMID: **.
13. Li Y, Wang X, He B, CaiH, Gao Y. Downregulation and tumor-suppressive role of XPO5 in hepatocellularcarcinoma. Mol Cell Biochem. 2016 Apr;415(1-2):197-205. doi:10.1007/s11010-016-2692-3. Epub 2016 Mar 21. PubMed PMID: **.
14. Li Q, Li Y, Wang Y, CuiZ, Gong L, Qu Z, Zhong Y, Zhou J, Zhou Y, Gao Y, Li Y. Quantitative proteomicstudy of human prostate cancer cells with different metastatic potentials. IntJ Oncol. 2016 Apr;48(4):1437-46. doi: 10.3892/ijo.2016.3378. Epub 2016 Feb 4.PubMed PMID: **.
15. Ye X, Zhang Y, He B, MengY, Li Y, Gao Y. Quantitative proteomic analysis identifies new effectors ofFOXM1 involved in breast cancer cell migration. Int J Clin Exp Pathol.2015;8(12):15836-44. eCollection 2015. PubMed PMID: **; PubMed CentralPMCID: PMC**.
16. Li Y, Lin Y, Li Q, Gao Y.SRrp35 suppresses cell proliferation and malignancy in hepatocellularcarcinoma. Hepatol Res. 2015 Dec;45(12):1241-7. doi: 10.1111/hepr.12493. Epub2015 Mar 17. PubMed PMID: **.
17. Chen Y, Cha Z, Fang W,Qian B, Yu W, Li W, Yu G, Gao Y. The prognostic potential and oncogenic effectsof PRR11 expression in hilar cholangiocarcinoma. Oncotarget. 2015 Aug21;6(24):20419-33. doi: 10.18632/oncotarget.3983. PubMed PMID: **; PubMedCentral PMCID: PMC**.
18. Feng C, Li X, Dong C,Zhang X, Zhang X, Gao Y. RGD-modified liposomes enhance efficiency ofaclacinomycin A delivery: evaluation of their effect in lung cancer. Drug DesDevel Ther. 2015;9:4613-20. doi: 10.2147/DDDT.S85993. eCollection 2015. PubMedPMID: **; PubMed Central PMCID: PMC**.
19. Cai H, Chen J, He B, LiQ, Li Y, Gao Y. A FOXM1 related long non-coding RNA contributes to gastriccancer cell migration. Mol Cell Biochem. 2015 Aug;406(1-2):31-41. doi:10.1007/s11010-015-2421-3. Epub 2015 Apr 24. PubMed PMID: **.
20. Cai H, Ye X, He B, Li Q,Li Y, Gao Y. LncRNA-AP001631.9 promotes cell migration in gastric cancer. Int JClin Exp Pathol. 2015;8(6):6235-44. eCollection 2015. PubMed PMID: **;PubMed Central PMCID: PMC**.
21. Chen J, Jiang H, Wu Y, LiY, Gao Y. A novel glycyrrhetinic acid-modified oxaliplatin liposome forliver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther.2015;9:2265-75. doi: 10.2147/DDDT.S81722. eCollection 2015. PubMed PMID:**; PubMed Central PMCID: PMC**.
22. Wang Y, Wang Q, Zhang N,Ma H, Gu Y, Tang H, Xu Z, Gao Y. Identification of microRNAs as novel biomarkersfor detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.Tumour Biol. 2014 Nov;35(11):11595-604. doi: 10.1007/s13277-014-2350-x. Epub2014 Aug 19. PubMed PMID: **.
23. Shi M, Cui J, Du J, WeiD, Jia Z, Zhang J, Zhu Z, Gao Y, Xie K. A novel KLF4/LDHA signaling pathwayregulates aerobic glycolysis in and progression of pancreatic cancer. ClinCancer Res. 2014 Aug 15;20(16):4370-80. doi: 10.1158/1078-0432.CCR-14-0186.Epub 2014 Jun 19. PubMed PMID: **; PubMed Central PMCID: PMC**.
24. Li Q, Tian Y, Li D, SunJ, Shi D, Fang L, Gao Y, Liu H. The effect of lipocisplatin on cisplatinefficacy and nephrotoxicity in malignant breast cancer treatment. Biomaterials.2014 Aug;35(24):6462-72. doi: 10.1016/j.biomaterials.2014.04.023. Epub 2014 May3. PubMed PMID: **.
25. Li Q, Wang H, Yu L, ZhouJ, Chen J, Zhang X, Chen L, Gao Y, Li Q. ChIP-seq predicted estrogen receptorbiding sites in human breast cancer cell line MCF7. Tumour Biol. 2014May;35(5):4779-84. doi: 10.1007/s13277-014-1627-4. Epub 2014 Jan 28. PubMedPMID: **.
26. Yang L, Yang S, Liu J,Wang X, Ji J, Cao Y, Lu K, Wang J, Gao Y. Expression of GRP78 predictstaxane-based therapeutic resistance and recurrence of human gastric cancer. ExpMol Pathol. 2014 Apr;96(2):235-41. doi: 10.1016/j.yexmp.2014.02.011. Epub 2014Mar 3. PubMed PMID: **.
27. Huang C, Xie D, Cui J, LiQ, Gao Y, Xie K. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymaltransition and metastasis via upregulation of expression of the urokinaseplasminogen activator system. Clin Cancer Res. 2014 Mar 15;20(6):1477-88. doi:10.1158/1078-0432.CCR-13-2311. Epub 2014 Jan 22. PubMed PMID: **; PubMedCentral PMCID: PMC**.
28. Luo JH, Zhou J, Gao Y.Correlation between periostin and SNCG and esophageal cancer invasion,infiltration and apoptosis. Asian Pac J Trop Med. 2013 Jul;6(7):516-9. doi:10.1016/S1995-7645(13)60088-7. PubMed PMID: **.
29. Jiang H, Lin Y, Yang CQ,Li Q, Luo J, Zhou Y, Xue J, Wei W, Gao Y. Quantitative assessment of theassociation between XRCC6 C1310G polymorphism and cancer risk. Tumour Biol.2013 Apr;34(2):779-85. doi: 10.1007/s13277-012-0607-9. Epub 2012 Dec 28. PubMedPMID: **.
30. Li Q, Gao Y, Xu ZG, JiangH, Yu YY, Zhu ZG. Effect of antisense oligodeoxynucleotide targeted againstNF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer. Clin ExpMed. 2013 Feb;13(1):11-9. doi: 10.1007/s10238-011-0174-1. Epub 2012 Jan 11.PubMed PMID: **.
31. Li Q, Gao Y, Jia Z,Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K. Dysregulated Krüppel-likefactor 4 and vitamin D receptor signaling contribute to progression ofhepatocellular carcinoma. Gastroenterology. 2012 Sep;143(3):799-810.e2. doi:10.1053/j.gastro.2012.05.043. Epub 2012 Jun 4. PubMed PMID: **; PubMedCentral PMCID: PMC**.
32. Jiang H, Zhang X, Luo J,Dong C, Xue J, Wei W, Chen J, Zhou J, Gao Y, Yang C. Knockdown of hMex-3A bysmall RNA interference suppresses cell proliferation and migration in humangastric cancer cells. Mol Med Rep. 2012 Sep;6(3):575-80. doi:10.3892/mmr.2012.943. Epub 2012 Jun 11. PubMed PMID: **.
33. Gao Y, Jia Z, Kong X, LiQ, Chang DZ, Wei D, Le X, Suyun H, Huang S, Wang L, Xie K. Combining betulinicacid and mithramycin a effectively suppresses pancreatic cancer by inhibitingproliferation, invasion, and angiogenesis. Cancer Res. 2011 Aug1;71(15):5182-93. doi: 10.1158/0008-5472.CAN-10-2016. Epub 2011 Jun 14. PubMedPMID: **; PubMed Central PMCID: PMC**.